U
UZ Gent | Polikliniek - Reumatologie Department
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Vericiguat
MK-6194
MK-1242-036
MK-6194-007
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 4 total trials
Researchers are looking for a new way to treat people with non-segmental vitiligo (NSV). The goal of this study is to learn about the safety of MK-61...
Active, not recruiting
Non-segmental Vitiligo
Biological: MK-6194
Drug: Placebo
The purpose of this study is to learn if V940 which is an individualized neoantigen therapy (INT; formerly, called messenger ribonucleic acid \[mRNA\...
Active, not recruiting
Melanoma
Biological: Pembrolizumab
Biological: V940
This study aims to compare the efficacy of vericiguat versus placebo on change in n-terminal pro-brain natriuretic peptide (NTproBNP) from baseline t...
Enrolling
Left Ventricular Systolic Dysfunction
Heart Failure
Drug: Vericiguat tablet
Drug: Placebo tablet
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems